Sandoz is a pioneer and global leader in generic and biosimilar medicines. For over a century, we have been discovering, developing and delivering medicines that have improved and extended the lives of millions of people around the world. At the forefront of our growing portfolio of over 1,000 molecules are market-leading biosimilars and generic antibiotics that are the backbone of modern healthcare, delivering significant and ongoing savings to ensure the sustainability of health systems. However, our commitment to society extends beyond the supply of medicines as we work to reduce our carbon footprint, play our part in combatting the growing threat of antimicrobial resistance and, generally, help to make our world a better, more sustainable and healthier place - today and for the generations yet to come.
